Chiron Concludes Phase III Program for Menjugate Meningococcal C Vaccine in United States
EMERYVILLE, Calif. -- Chiron Corporation announced that it has successfully concluded its Phase III trial for Menjugate® meningococcal C vaccine in the United States and will not be filing a Biologics License Application (BLA) for the vaccine. The now-completed Phase III trial in the United States expanded the safety and immunogenicity database for Menjugate, a conjugated vaccine.
Given the changing landscape for meningococcal vaccines in the United States, we believe that our resources are better deployed by focusing on advancing our quadravalent vaccine candidate for serogroups A, C, W and Y, said John Lambert, president, Chiron Vaccines. We have learned a great deal from the Phase III study of Menjugate, and we will apply that experience to move our ACWY vaccine candidate through development.
Chirons meningococcal ACWY vaccine is currently in Phase II. The company initiated a Phase II study in infants this year and plans to initiate a Phase III program for the vaccine in 2005.
Source: Chiron
Pioneering Advances in Sterilization: The Future of Infection Control
November 28th 2024Germitec, STERIS, ASP, and Zuno Medical are pioneering sterilization advancements with groundbreaking technologies that enhance SPD workflows, improve patient safety, and redefine infection control standards.
Genomic Surveillance A New Frontier in Health Care Outbreak Detection
November 27th 2024According to new research, genomic surveillance is transforming health care-associated infection detection by identifying outbreaks earlier, enabling faster interventions, improving patient outcomes, and reducing costs.
Point-of-Care Engagement in Long-Term Care Decreasing Infections
November 26th 2024Get Well’s digital patient engagement platform decreases hospital-acquired infection rates by 31%, improves patient education, and fosters involvement in personalized care plans through real-time interaction tools.
Comprehensive Strategies in Wound Care: Insights From Madhavi Ponnapalli, MD
November 22nd 2024Madhavi Ponnapalli, MD, discusses effective wound care strategies, including debridement techniques, offloading modalities, appropriate dressing selection, compression therapy, and nutritional needs for optimal healing outcomes.
